Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Bioconjugate Chemistry|January 20, 2005
Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphomaKevin J Hamblett, Oliver W Press, Damon L Meyer, et al.Blood|March 25, 2006
Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomasJohn M Pagel, Yukang Lin, Nathan Hedin, et al.Bioconjugate Chemistry|May 16, 2002
A streptavidin-biotin binding system that minimizes blocking by endogenous biotinKevin J Hamblett, Brian B Kegley, Don K Hamlin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 7, 2003
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenograftsKrishnan Subbiah, Don K Hamlin, John M Pagel, et al.Blood|August 13, 2010
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual diseaseSteven I Park, Jaideep Shenoi, John M Pagel, et al.Pageof 1